CD8A and neoplasm: Remarkably, the FMT from long-term survivors enhanced the CD8+IFNg+ T cell infiltration, reduced FoxP3+ Tregs and Ly6G/Ly6C+ MDSCs, and reduced tumor growth in the recipient mice.